Erratum: Immune cell functional assay in monitoring of adult liver transplantation recipients with infection (Transplantation (2010) 89 (620-626) DOI: 10.1097/TP.0b013e3181c690fa);Immune cell functional assay in monitoring of adult liver transplantation recipients with infection

Transplantation

Volumn 89, Issue 5, 2010, Pages 620-626

  Xue, Feng ^a   Zhang, Jianjun ^a   Han, Longzhi ^a   Li, Qigen ^a   Xu, Ning ^a   Zhou, Tao ^a   Xi, Zhifeng ^a   Wu, Youmin ^b   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

ATP; ImmuKnow; Immune function assay; Infection; Liver transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ABDOMINAL INFECTION; ADULT; ARTICLE; BILIARY TRACT INFECTION; BLOOD CULTURE; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL FUNCTION; CELLULAR IMMUNITY; CHINESE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HELPER CELL; HUMAN; IMMUNOASSAY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION;

EID: 77949414863     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000002824     Document Type: Erratum

References (23)

1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601.
2. Torbenson M, Wang J, Nichols L, et al. Causes of death in autopsied liver transplantation patients. Mod Pathol 1998; 11: 37.
3. Garbino J, Romand JA, Pittet D, et al. Infection and rejection in liver transplant patients: A 10-year Swiss single-centre experience. Swiss Med Wkly 2005; 135: 587.
4. Humar A, Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262.
5. Fishman JA. Vancomycin-resistant enterococcus in liver transplantation: What have we left behind? Transpl Infect Dis 2003; 5: 109.
6. Del Pozo JL. Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol 2008; 14: 4977.
7. Davies JK, Yuk D, Nadler LM, et al. Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity. Transplantation 2008; 86: 854.
8. Hadaya K, de Rham C, Bandelier C, et al. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 2008; 8: 2674.
9. Alakulppi N, Seikku P, Jaatinen T, et al. Feasibility of diagnosing subclinical renal allograft rejection in children by whole blood gene expression analysis. Transplantation 2008; 86: 1222.
10. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005; 19:834.
11. Israeli M, Klein T, Sredni B, et al. ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl2008; 14: 893.
12. Israeli M, Yussim A, Mor E, et al. Preceeding the rejection: In search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007; 18: 7.
13. Bhorade SM, Janata K, Vigneswaran WT, et al. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990.
14. Gautam A, Fischer SA, Yango AF, et al. Cell mediated immunity (CMI) and post transplant viral infections\Role of a functional immune assay to titrate immunosuppression. Int Immunopharmacol 2006; 6: 2023.
15. + adenosine triphosphate activity in a liver transplant cohort: Insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl 2008; 14: 1313.
16. Sampson VB, Dunn SP, Rymeski B, et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. JPediatr Surg 2008; 43: 1134.
17. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77.
18. Gupta S, Mitchell JD, Markham DW, et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant 2008; 27: 817.
19. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663.
20. + helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation 1993; 56:590.
21. Ahmed M, Venkataraman R, Logar AJ, et al. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(\) andCD8(+) peripheral blood T cells. Ther DrugMonit 2001; 23: 354.
22. Baumgartner JM, Silliman CC, Moore EE, et al. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 2009; 208: 110.
23. Kawasaki T, Choudhry MA, Schwacha MG, et al. Trauma-hemorrhage inhibits splenic dendritic cell proinflammatory cytokine production via a mitogen-activated protein kinase process. Am J Physiol Cell Physiol 2008; 294: C754.